/

/

EXCLUSIVE: Non-Hallucinogenic Psychedelic Compounds Show Promise For Treating Addiction And ADHD -...

Wed, Feb 26

🚨 EXCLUSIVE: Non-hallucinogenic psychedelics could reshape addiction & ADHD treatment. @Enveric_Bio secures patent for compounds targeting key brain receptors without hallucinatory effects Read on @Benzinga 🔗 Read more: https://t.co/tDO19bRT6S $ENVB

2247

Enveric Biosciences secures a U.S. patent for non-hallucinogenic mescaline derivatives targeting addiction, ADHD and anxiety.

Discover